???global.info.a_carregar???
BSousa is a junior researcher at the Cancer Metastasis group at i3S, focusing on elucidating the mechanisms underlying the survival and therapeutic resistance of circulating tumor cells in metastatic breast cancer patients, with the ultimate aim of establishing a precision oncology platform. BSousa performed her Biochemistry BSc trainee at IPATIMUP, in 2007, being immediately awarded with a research grant in a collaboration project with SANOFI-Aventis. During this period, she built and molecularly characterize a large series of breast carcinomas, pinpointing specific biomarkers that were able to better identify basal-like breast cancer (PMID:20552547). In 2014, she completed her PhD in Pathology and Molecular Genetics, at ICBAS. BSousa demonstrated that cell-cell adhesion awarded by P-cadherin expression plays a role in breast cancer cell metabolism (PMID:25269858). This work was supervised by Joana Paredes and developed at Ipatimup (Porto, Portugal), with two international stays at Patterson Institute for Cancer Research, PICR (Manchester, UK), and at R&D department of Sanofi-Aventis (Toulouse, France). In 2015, she was awarded with a competitive FCT Postdoc grant to pursuit the ongoing projects, specifically on the role of P-cadherin in the oxidative stress impairment, and its impact in the metastatic process (PMID: 32920119). In this context, she joined Paulo Oliveira's lab, at UC-Biotech, Cantanhede, where she expanded her technical skills and solid expertise in cancer metabolism, namely with the Seahorse Technology, thus going further in her independent pathway. During this period, BSousa was also involved in the conception and writing of several funded grants, in which I participated as task leader, providing wet-lab support, as well as data analysis on her areas of expertise. She still published a review manuscript (PMID:31010154) and a book chapter (PMID: 31134496). In 2019, BSousa was awarded a Junior Researcher contract at i3S. She established in vitro 3D breast cancer cell spheroids and immune spheroids as models to answer the questions raised in her work, thus implementing a new scientific topic within her host group, dedicated to the study the mechanisms associated to the survival of circulating tumor cells (CTCs). As a member of the Porto Comprehensive Cancer Center (P.CCC)-Raquel Seruca consortium, she implemented a lab with specialized equipment, to isolate and characterize CTCs: the FDA-approved CellSearch, as well as DEPArrayPLUS technology, for which she is one of the three national certified users. This opportunity gave her the know-how, and the opportunity to close collaborate with clinical oncologists, enhancing the impact of her research line. During her career path, BSousa still actively pursued specific activities towards an independent career. She supervised one master student (2017), one international internship (2019), as well as she is currently co-supervising one master and two FCT-funded PhD students, recently awarded by Fulbright Portugal, Liga Portuguesa contra o Cancro and Sociedade Portuguesa de Oncologia. She is actively involved in scientific diffusion by the frequent invitations to lecture at GABBA and BEB PhD programs, as well as in medicine graduation at FMUP. She also attended different workshops/courses, such as Animal Science (FELASA C) and Research Project Management, and participated as an evaluator in national meetings. Her solid track record, in the last 5 years (including one maternity leave in 2021), is reflected in 7 papers (2 papers as 1st author and 5 as co-author) in international peer-reviewed journals and one book chapter. In total, I authored 28 publications, specifically being 1st author of 3 original papers and one review. The capacity to disseminate her results is reflected in the frequent invitations to speak in international cancer metabolism meetings, as well as in being selected for oral communications from first-author abstracts.
Ler resumo completo ↓
Identificação

Identificação pessoal

Nome completo
Bárbara Beatriz Pinheiro Ribeiro de Sousa

Nomes de citação

  • Sousa, Bárbara

Identificadores de autor

Ciência ID
5816-C95D-1E6F
ORCID iD
0000-0002-0990-022X
Researcher Id
K-8854-2014
Scopus Author Id
12777326600

Endereços de correio eletrónico

  • bsousa@ipatimup.pt (Profissional)
  • bbeatrizs@gmail.com (Pessoal)

Moradas

  • Rua Alfredo Allen 208, , 4200-135 , Porto, Porto, Portugal (Profissional)

Websites

Domínios de atuação

  • Ciências Médicas e da Saúde - Medicina Básica

Idiomas

Idioma Conversação Leitura Escrita Compreensão Peer-review
Português (Idioma materno)
Inglês Utilizador proficiente (C1) Utilizador proficiente (C1) Utilizador proficiente (C1) Utilizador proficiente (C1) Utilizador proficiente (C1)
Formação
Grau Classificação
2023/06/13 - 2023/06/29
Em curso
 Research Project Management, 3rd edition (Outros)
Universidade do Porto Instituto de Investigação e Inovação em Saúde, Portugal
2015/01/01 - 2018/12/31
Concluído
 P-cadherin breast cancer stem cell marker: an antioxidant for metabolic defects caused by loss of matrix attachment (Pós-doutoramento)
Universidade do Porto Instituto de Patologia e Imunologia Molecular, Portugal
2018/09/10 - 2018/09/21
Concluído
 Laboratory Animal Science-FELASA C (Outros)
Universidade do Porto Instituto de Investigação e Inovação em Saúde, Portugal
2010/01/01 - 2014/12/15
Concluído
 Pathology and Molecular Genetics (Doutoramento)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
"Underlying the role of P-cadherin expression in breast cancer cell metabolism" (TESE/DISSERTAÇÃO)
2001/09/06 - 2007/07/28
Concluído
 Bioquímica (Licenciatura)
Universidade de Coimbra Faculdade de Ciencias e Tecnologia, Portugal
"Immunohistochemical characterization of a series of invasive breast carcinomas using Tissue Microarrays" (TESE/DISSERTAÇÃO)
 15/20
Percurso profissional

Ciência

Categoria Profissional
Instituição de acolhimento 		Empregador
2019/01/01 - Atual Investigador Contratado (Investigação) Universidade do Porto Instituto de Investigação e Inovação em Saúde, Portugal
Universidade do Porto Instituto de Investigação e Inovação em Saúde, Portugal
2015/01/01 - 2018/12/31 Pós-doutorado (Investigação) Fundação para a Ciência e a Tecnologia, Portugal
Universidade do Porto Instituto de Patologia e Imunologia Molecular, Portugal
2016/06/01 - 2016/08/05 Investigador visitante (Investigação) Universidade de Coimbra Centro de Neurociências e Biologia Celular, Portugal
Universidade de Coimbra Centro de Neurociências e Biologia Celular, Portugal
2013/06/01 - 2013/07/31 Investigador visitante (Investigação) Biopark by Sanofi, França
Biopark by Sanofi, França
2012/10/01 - 2012/12/17 Investigador visitante (Investigação) PICR (Paterson Institute for Cancer Research, University of Manchester, Manchester), Reino Unido
PICR (Paterson Institute for Cancer Research, University of Manchester, Manchester), Reino Unido
2008/01/01 - 2009/12/31 Investigador Contratado (Investigação) Universidade do Porto Instituto de Patologia e Imunologia Molecular, Portugal
Universidade do Porto Instituto de Patologia e Imunologia Molecular, Portugal
2007/07/01 - 2007/12/31 Estagiário de Investigação (Investigação) Universidade de Coimbra Faculdade de Ciencias e Tecnologia, Portugal
Universidade do Porto Instituto de Patologia e Imunologia Molecular, Portugal

Outros

Categoria Profissional
Instituição de acolhimento 		Empregador
2010/01/01 - 2014/12/31 PhD student Fundação para a Ciência e a Tecnologia, Portugal
Universidade do Porto Instituto de Patologia e Imunologia Molecular, Portugal
Projetos

Bolsa

Designação Financiadores
2022/09/01 - 2023/08/08 Development of a workflow to capture circulating tumour cell (CTC) clusters from patients with metastatic breast cancer
CANCER METASTASIS
Investigador
Liga Portuguesa Contra o Cancro, Portugal
Concluído
2008/09/01 - 2010/12/31 P-cadherin Expression: its effect in breast cancer metastasis and angiogenesis using in vivo animal models
SANO-AV
Bolseiro de Investigação
Concluído

Outro

Designação Financiadores
2018/06/01 - 2021/07/31 HOXB genes function in breast cancer
POCI-01-0145-FEDER-030562
Investigador
2017/01/01 - 2019/12/31 Tackling CANcer STEM CELls: a challenge and an opportunity to advance in anti-cancer therapy
SAICTPAC/0022/2015 - POCI-01-0145-FEDER-016390
Investigador
2016/05/01 - 2019/04/30 P-cadherin breast cancer stem cell marker: an anti-oxidant for metabolic defects caused by loss of matrix attachment
NORTE-01-0145-FEDER-00029
Investigador
Fundação para a Ciência e a Tecnologia
Em curso
2014/06/01 - 2015/05/05 Dasatinib as an option to treat P-cadherin-overexpressing poor prognosis breast cancer
Laço
Investigador
Concluído
2012/03/01 - 2015/02/28 ADHESION, DIFFERENTIATION AND INVASION: DIFFERENT PROCESSES, COMMON CADHERIN PLAYERS
info:eu-repo/grantAgreement/FCT/SFRH/SFRH2%FBPD2%F757052%F2011/PT
Investigador
Fundação para a Ciência e a Tecnologia
Concluído
Produções

Publicações

Artigo em revista
  1. Fonseca, Irina; Horta, Cíntia; Ribeiro, Ana Sofia; Sousa, Barbara; Marteil, Gaëlle; Bettencourt-Dias, Mónica; Paredes, Joana. "Polo-like kinase 4 (Plk4) potentiates anoikis-resistance of p53KO mammary epithelial cells by inducing a hybrid EMT phenotype". Cell Death & Disease 14 2 (2023): http://dx.doi.org/10.1038/s41419-023-05618-1.
    10.1038/s41419-023-05618-1
  2. Tavares-Valente, Diana; Sousa, Bárbara; Schmitt, Fernando; Baltazar, Fátima; Queirós, Odília. "Disruption of pH Dynamics Suppresses Proliferation and Potentiates Doxorubicin Cytotoxicity in Breast Cancer Cells". (2021):
    10.3390/pharmaceutics13020242
  3. Sousa, Bárbara; Pereira, Joana; Marques, Ricardo; Grilo, Luís F.; Pereira, Susana P.; Sardão, Vilma A.; Schmitt, Fernando; Oliveira, Paulo J.; Paredes, Joana. "P-cadherin induces anoikis-resistance of matrix-detached breast cancer cells by promoting pentose phosphate pathway and decreasing oxidative stress". Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1866 12 (2020): 165964. http://dx.doi.org/10.1016/j.bbadis.2020.165964.
    10.1016/j.bbadis.2020.165964
  4. Flávia Martins; Rosa Oliveira; Bruno Cavadas; Filipe Pinto; Ana Cardoso; Flávia Castro; Bárbara Sousa; et al. "Hypoxia and Macrophages Act in Concert Towards a Beneficial Outcome in Colon Cancer". Cancers (2020): https://www.mdpi.com/2072-6694/12/4/818.
    10.3390/cancers12040818
  5. Bárbara Sousa; Joana Pereira; Joana Paredes. "The Crosstalk Between Cell Adhesion and Cancer Metabolism". International Journal of Molecular Sciences (2019): https://www.mdpi.com/1422-0067/20/8/1933.
    10.3390/ijms20081933
  6. Ribeiro, Ana Sofia; Nobre, Ana Rita; Mendes, Nuno; Almeida, João; Vieira, André Filipe; Sousa, Bárbara; Carvalho, Filomena A.; et al. "SRC inhibition prevents P-cadherin mediated signaling and function in basal-like breast cancer cells". Cell Communication and Signaling 16 1 (2018): http://dx.doi.org/10.1186/s12964-018-0286-2.
    10.1186/s12964-018-0286-2
  7. Hoffmann C; Mao X; Brown-Clay J; Moreau F; Al Absi A; Wurzer H; Sousa B; et al. "Hypoxia promotes breast cancer cell invasion through HIF-1a-mediated up-regulation of the invadopodial actin bundling protein CSRP2.". Scientific reports (2018): http://europepmc.org/abstract/med/29976963.
    10.1038/s41598-018-28637-x
  8. Figueiredo J; Rodrigues I; Ribeiro J; Fernandes MS; Melo S; Sousa B; Paredes J; Seruca R; Sanches JM. "Geometric compensation applied to image analysis of cell populations with morphological variability: a new role for a classical concept.". Scientific reports (2018): http://europepmc.org/abstract/med/29980764.
    10.1038/s41598-018-28570-z
  9. Oliveira P; Carvalho J; Rocha S; Azevedo M; Reis I; Camilo V; Sousa B; et al. "Dies1/VISTA expression loss is a recurrent event in gastric cancer due to epigenetic regulation.". (2016): http://europepmc.org/abstract/med/27721458.
    10.1038/srep34860
  10. Vieira, A.F.; Ribeiro, A.S.; Dionísio, M.R.; Sousa, B.; Nobre, A.R.; Albergaria, A.; Santiago-Gómez, A.; et al. "P-cadherin signals through the laminin receptor a6ß4 integrin to induce stem cell and invasive properties to basal-like breast cancer cells". Oncotarget 5 3 (2014): 679-692. http://www.scopus.com/inward/record.url?eid=2-s2.0-84896821980&partnerID=MN8TOARS.
  11. Sousa, B.; Ribeiro, A.S.; Nobre, A.R.; Lopes, N.; Martins, D.; Pinheiro, C.; Vieira, A.F.; et al. "The basal epithelial marker P-cadherin associates with breast cancer cell populations harboring a glycolytic and acid-resistant phenotype". BMC Cancer 14 1 (2014): http://www.scopus.com/inward/record.url?eid=2-s2.0-84908094892&partnerID=MN8TOARS.
    10.1186/1471-2407-14-734
  12. Moniz, S.; Martinho, O.; Pinto, F.; Sousa, B.; Loureiro, C.; Oliveira, M.J.; Moita, L.F.; et al. "Loss of WNK2 expression by promoter gene methylation occurs in adult gliomas and triggers Rac1-mediated tumour cell invasiveness". Human Molecular Genetics 22 1 (2013): 84-95. http://www.scopus.com/inward/record.url?eid=2-s2.0-84871200220&partnerID=MN8TOARS.
    10.1093/hmg/dds405
  13. Albergaria, A.; Resende, C.; Nobre, A.R.; Ribeiro, A.S.; Sousa, B.; Machado, J.C.; Seruca, R.; Paredes, J.; Schmitt, F.. "CCAAT/Enhancer Binding Protein ß (C/EBPß) Isoforms as Transcriptional Regulators of the Pro-Invasive CDH3/P-Cadherin Gene in Human Breast Cancer Cells". PLoS ONE 8 2 (2013): http://www.scopus.com/inward/record.url?eid=2-s2.0-84873547668&partnerID=MN8TOARS.
    10.1371/journal.pone.0055749
  14. Ribeiro, A.S.; Sousa, B.; Carreto, L.; Mendes, N.; Nobre, A.R.; Ricardo, S.; Albergaria, A.; et al. "P-cadherin functional role is dependent on E-cadherin cellular context: A proof of concept using the breast cancer model". Journal of Pathology 229 5 (2013): 705-718. http://www.scopus.com/inward/record.url?eid=2-s2.0-84875054847&partnerID=MN8TOARS.
    10.1002/path.4143
  15. Martins, D.; Beça, F.F.; Sousa, B.; Baltazar, F.; Paredes, J.; Schmitt, F.. "Loss of caveolin-1 and gain of MCT4 expression in the tumor stroma Key events in the progression from an in situ to an invasive breast carcinoma". Cell Cycle 12 16 (2013): 2684-2690. http://www.scopus.com/inward/record.url?eid=2-s2.0-84883237456&partnerID=MN8TOARS.
    10.4161/cc.25794
  16. Lopes, N.; Carvalho, J.; Durães, C.; Sousa, B.; Gomes, M.; Costa, J.L.; Oliveira, C.; Paredes, J.; Schmitt, F.. "1Alpha,25-dihydroxyvitamin D 3 induces de novo E-cadherin expression in triple-negative breast cancer cells by CDH1-promoter demethylation". Anticancer Research 32 1 PART 2 (2012): 249-257. http://www.scopus.com/inward/record.url?eid=2-s2.0-84856024024&partnerID=MN8TOARS.
  17. Albergaria, A.; Ribeiro, A.-S.; Vieira, A.-F.; Sousa, B.; Nobre, A.-R.; Seruca, R.; Schmitt, F.; Paredes, J.. "P-cadherin role in normal breast development and cancer". International Journal of Developmental Biology 55 7-9 (2011): 811-822. http://www.scopus.com/inward/record.url?eid=2-s2.0-82555201366&partnerID=MN8TOARS.
    10.1387/ijdb.113382aa
  18. Martins, D.; Sousa, B.; Lopes, N.; Gomes, M.; Veronese, L.; Albergaria, A.; Paredes, J.; Schmitt, F.. "Molecular phenotypes of matched in situ and invasive components of breast carcinomas". Human Pathology 42 10 (2011): 1438-1446. http://www.scopus.com/inward/record.url?eid=2-s2.0-80053182840&partnerID=MN8TOARS.
    10.1016/j.humpath.2010.08.024
  19. Pinheiro, C.; Sousa, B.; Albergaria, A.; Paredes, J.; Dufloth, R.; Vieira, D.; Schmitt, F.; Baltazar, F.. "GLUT1 and CAIX expression profiles in breast cancer correlate with adverse prognostic factors and MCT1 overexpression". Histology and Histopathology 26 10 (2011): 1279-1286. http://www.scopus.com/inward/record.url?eid=2-s2.0-80053319008&partnerID=MN8TOARS.
  20. Ribeiro, A.S.; Albergaria, A.; Sousa, B.; Correia, A.L.; Bracke, M.; Seruca, R.; Schmitt, F.C.; Paredes, J.. "Extracellular cleavage and shedding of P-cadherin: A mechanism underlying the invasive behaviour of breast cancer cells". Oncogene 29 3 (2010): 392-402. http://www.scopus.com/inward/record.url?eid=2-s2.0-75149183984&partnerID=MN8TOARS.
    10.1038/onc.2009.338
  21. Albergaria, A.; Ribeiro, A.S.; Pinho, S.; Milanezi, F.; Carneiro, V.; Sousa, B.; Sousa, S.; et al. "ICI 182,780 induces P-cadherin overexpression in breast cancer cells through chromatin remodelling at the promoter level: A role for C/EBPß in CDH3 gene activation". Human Molecular Genetics 19 13 (2010): 2554-2566. http://www.scopus.com/inward/record.url?eid=2-s2.0-77954172745&partnerID=MN8TOARS.
    10.1093/hmg/ddq134
  22. Pinheiro, C.; Albergaria, A.; Paredes, J.; Sousa, B.; Dufloth, R.; Vieira, D.; Schmitt, F.; Baltazar, F.. "Monocarboxylate transporter 1 is up-regulated in basal-like breast carcinoma". Histopathology 56 7 (2010): 860-867. http://www.scopus.com/inward/record.url?eid=2-s2.0-77953195898&partnerID=MN8TOARS.
    10.1111/j.1365-2559.2010.03560.x
  23. Sousa, B.; Paredes, J.; Milanezi, F.; Lopes, N.; Martins, D.; Dufloth, R.; Vieira, D.; et al. "P-cadherin, Vimentin and CK14 for identification of basal-like phenotype in breast carcinomas: An immunohistochemical study". Histology and Histopathology 25 8 (2010): 963-974. http://www.scopus.com/inward/record.url?eid=2-s2.0-77956895496&partnerID=MN8TOARS.
  24. Lopes, N.; Sousa, B.; Martins, D.; Gomes, M.; Vieira, D.; Veronese, L.A.; Milanezi, F.; et al. "Alterations in Vitamin D signalling and metabolic pathways in breast cancer progression: A study of VDR, CYP27B1 and CYP24A1 expression in benign and malignant breast lesions Vitamin D pathways unbalanced in breast lesions". BMC Cancer 10 (2010): http://www.scopus.com/inward/record.url?eid=2-s2.0-77956478256&partnerID=MN8TOARS.
    10.1186/1471-2407-10-483
  25. Ribeiro AS; Carreto LC; Albergaria A; Sousa B; Ricardo S; Milanezi F; Seruca R; et al. "Co-expression of E- and P-cadherin in breast cancer: role as an invasion suppressor or as an invasion promoter?". (2010): http://europepmc.org/abstract/PMC/PMC3255045.
  26. Rodrigues, Ligia R.; Lopes, Nair; Sousa, Barbara; Vieira, Daniella; Milanezi, Fernanda; Paulsson, Marie; Lindmark-Mansson, Helena; Teixeira, Jose A.; Schmitt, Fernando. "Significance of Osteopontin Expression in Human Invasive Breast Tumour Stroma". The Open Breast Cancer Journal 1 1 (2009): 1-9. http://dx.doi.org/10.2174/1876817200901010001.
    10.2174/1876817200901010001
  27. Lopes, N.; Sousa, B.; Vieira, D.; Milanezi, F.; Schmitt, F.. "Vessel density assessed by endoglin expression in breast carcinomas with different expression profiles". Histopathology 55 5 (2009): 594-599. http://www.scopus.com/inward/record.url?eid=2-s2.0-71049118533&partnerID=MN8TOARS.
    10.1111/j.1365-2559.2009.03417.x
  28. Albergaria, A.; Paredes, J.; Sousa, B.; Milanezi, F.; Carneiro, V.; Bastos, J.; Costa, S.; et al. "Expression of FOXA1 and GATA-3 in breast cancer: The prognostic significance in hormone receptor-negative tumours". Breast Cancer Research 11 3 (2009): http://www.scopus.com/inward/record.url?eid=2-s2.0-74049137968&partnerID=MN8TOARS.
    10.1186/bcr2327
Capítulo de livro
  1. Sousa, Bárbara; Ribeiro, Ana Sofia; Paredes, Joana. "Heterogeneity and Plasticity of Breast Cancer Stem Cells". In Advances in Experimental Medicine and Biology, 83-103. Springer International Publishing, 2019.
    Publicado • 10.1007/978-3-030-14366-4_5
Poster em conferência
  1. Castro, Maria Miguel. "O impacto da perda de adesão célula-célula na sobrevivência de êmbolos tumorais de cancro da mama inflamatório (co-supervision)". Trabalho apresentado em ENJIO 2023, Liga Portuguesa Contra o Cancro, 2023, 2024.
  2. Castro, Maria Miguel. "Cell-cell adhesion disruption impacts the survival of inflammatory breast cancer cells (co-supervision)". Trabalho apresentado em XXII Porto Cancer Meeting, IPATIMUP, Porto, Portugal, 2024.
  3. Sousa, Bárbara. "Development of a workflow to capture circulating tumor cell (CTC) clusters from patients with metastatic breast cancer". Trabalho apresentado em XXII Porto Cancer Meeting, IPATIMUP, Porto, Portugal, 2024.
  4. Esquível, Catarina. "P-cadherin expression is a biomarker of a hybrid EMT phenotype (co-supervision)". Trabalho apresentado em XXII Porto Cancer Meeting, IPATIMUP, Porto, Portugal, 2024.
  5. Sousa, Bárbara. "Development of a workflow to capture circulating tumor cell (CTC) clusters from patients with metastatic breast cancer". Trabalho apresentado em 6th ASPIC International Congress, 2024.
  6. Esquível, Catarina. "P-cadherin expression is a biomarker of a hybrid EMT phenotype (co-supervision)". Trabalho apresentado em 6th ASPIC International Congress, 2024.
  7. Castro, Maria Miguel. "The impact of cell-cell adhesion disruption on the survival of Inflammatory Breast Cancer tumor emboli (co-supervision)". Trabalho apresentado em Porto Cancer Meeting, IPATIMUP, Porto, Portugal, 2023.
  8. cristiana moreira tomaz. "P-cadherin-mediated cell-cell adhesion: Its role on immune evasion in metastasis breast cancer (co-supervision)". Trabalho apresentado em IJUP Edition, Encontro de Investigação Jovem, Porto, Portugal, 2023.
  9. cristiana moreira tomaz. "A adesão célula-célula mediada pela caderina-P induz um metabolismo glicolítico em células do cancro da mama (co-supervision)". Trabalho apresentado em ENJIO 2023, Liga Portuguesa Contra o Cancro, 2023, 2022.
  10. Esquível, Catarina. "P-cadherin as a phenotypic stability factor of the Hybrid Epithelial / Mesenchymal phenotype in Breast Cancer (co-supervision)". Trabalho apresentado em 4º Encontro Nacional de Jovens Investigadores em Oncologia (ENJIO), 2022.
  11. Castro, Maria Miguel. "The role of cell-cell adhesion in the survival of inflammatory breast cancer tumour emboli (co-supervision)". Trabalho apresentado em 5th ASPIC International Congress, 2022.
  12. Esquível, Catarina. "P-cadherin as a phenotypic stability factor of the Hybrid Epithelial / Mesenchymal phenotype in Breast Cancer (co-supervision)". Trabalho apresentado em 5th ASPIC International Congress, 2022.
  13. Castro, Maria Miguel. "The role of cell-cell adhesion in the survival of inflammatory breast cancer tumour emboli (co-supervision)". Trabalho apresentado em Porto Cancer Meeting, IPATIMUP, Porto, Portugal, 2022.
  14. Castro, Maria Miguel. "Effect of cell-cell adhesion disruption on anoikis resistance and aggregation in Inflammatory Breast Cancer Cells (co-supervision)". Trabalho apresentado em 5th PhDay, i3S, 2022.
  15. Sousa, Bárbara. "The anti-oxidant activity of P-cadherin promotes metastasis and doxorubicin resistance in breast cancer". Trabalho apresentado em EACR-AACR-ASPIC 2020 Conference: Tumor Microenvironment, Lisbon, Portugal, 2020.
  16. Sousa, Bárbara. "P-cadherin induces anoikis resistance in breast cancer stem cells by rewiring the metabolic flux and activating of antioxidant systems". Trabalho apresentado em FEBS ADVANCED LECTURE COURSE ON ONCOMETABOLISM: From Conceptual Knowledge to Clinical Applications, Luso, Portugal, 2019.
  17. Sousa, Bárbara. "P-cadherin induces anoikis resistance in breast cancer stem cells by rewiring the metabolic flux and activating of antioxidant systems". Trabalho apresentado em ISCaM 6th annual Meeting- Metabolic Adaptations and targets in Cancer, from International Society of Cancer Metabolism, Braga, Portugal, 2019.
  18. Sousa, Bárbara. "P-cadherin promotes anoikis resistance in breast cancer stem cells by stimulating the glycolytic behavior and lowering he oxidative stress". Trabalho apresentado em 3rd ASPIC International Congress, Lisbon, Portugal, 2018.
  19. Sousa, Bárbara. "P-cadherin enrichment dictates sensitivity of breast cancer cells to DCA metabolic reprogramming". Trabalho apresentado em ISCaM 5th annual Meeting- Metabolic Adaptations and targets in Cancer, from International Society of Cancer Metabolism, Bratislava, Slovakia, 2018.
  20. Sousa, Bárbara. "P-cadherin promotes anoikis resistance in breast cancer stem cells by stimulating the glycolytic behavior and lowering the oxidative stress". Trabalho apresentado em 7th I3S Annual Meeting, Póvoa de Varzim, Portugal, 2018.
  21. Sousa, Bárbara. "Targeting anoikis-resistant P-cadherin-enriched Breast Cancer Cells by in vitro Metabolic Reprograming". Trabalho apresentado em 10th IJUP Edition, Encontro de Investigação Jovem, Porto, Portugal, 2017.
  22. Sousa, Bárbara. "P-cadherin enrichment dictates sensitivity of breast cancer cells to DCA metabolic reprogramming". Trabalho apresentado em FEBS ADVANCED LECTURE COURSE ON ONCOMETABOLISM: From Conceptual Knowledge to Clinical Applications, Figueira da Foz, Portugal, 2017.
  23. Sousa, Bárbara. "P-cadherin: an antioxidant for metabolic defects in breast cancer stem cells?". Trabalho apresentado em 4th I3S Annual Meeting, Póvoa de Varzim, Portugal, 2016.
  24. Sousa, Bárbara. "The basal epitelial marker P-cadherin associates with breast cancer cell population harbouring a hypoxia-resistant phenotype". Trabalho apresentado em 5th French Cell Adhesion Club Symposium, Marseille, France, 2014.
  25. Sousa, Bárbara. "P-cadherin expression: its role in the regulation of metabolic properties of breast cancer stem cells". Trabalho apresentado em 1st ASPIC International Congress, Lisbon, Portugal, 2014.
  26. Sousa, Bárbara. "P-cadherin expression: its role in the regulation of metabolic properties of breast cancer stem cells". Trabalho apresentado em 4th I3S Annual Meeting, Póvoa de Varzim, Portugal, 2014.
  27. Sousa, Bárbara. "P-cadherin expression in breast cancer: its association with glycolytic and acid-resistant phenotypes". Trabalho apresentado em XXII Porto Cancer Meeting, IPATIMUP, Porto, Portugal, 2013.
  28. Sousa, Bárbara. "Aberrant expression of the CSC marker P-cadherin is associated with hypoxic/ glycolytic and acid resistant phenotype in breast carcinomas". Trabalho apresentado em 28th IABCR/Breakthrough Breast Cancer Conference, Manchester, UK, 2012.
  29. Sousa, Bárbara. "Aberrant expression of the CSC marker P-cadherin is associated with hypoxic/ glycolytic and acid resistant phenotype in breast carcinomas". Trabalho apresentado em : XXI Porto Cancer Meeting, IPATIMUP, Porto, Portugal, 2012.
  30. Sousa, Bárbara. "Aberrant expression of the CSC marker P-cadherin is associated with hypoxic/ glycolytic and acid resistant phenotype in breast carcinomas". Trabalho apresentado em 7th International Meeting of the Portuguese Society for Stem Cells and Cell Therapies (SPCE-TC), Biblioteca Almeida Garret, Jardins do Palácio de Cristal, Porto, Portugal, 2012.
  31. Sousa, Bárbara. "P-cadherin cancer stem cell marker: its role in breast cancer brain metastasis". Trabalho apresentado em : 7th International Meeting of the Portuguese Society for Stem Cells and Cell Therapies (SPCE-TC), Biblioteca Almeida Garret, Jardins do Palácio de Cristal, Porto, Portugal, 2012.
  32. Sousa, Bárbara. "Aberrant P-cadherin expression is associated with glycolytic and acid-resistant phenotype in invasive breast carcinoma". Trabalho apresentado em : 3rd I3S Annual Meeting, Póvoa de Varzim, Portugal, 2012.
  33. Sousa, Bárbara. "P-cadherin activates Src-kinase: A new signaling pathway with implications in breast cancer progression". Trabalho apresentado em 3rd I3S Annual Meeting, Póvoa de Varzim, Portugal, 2012.
  34. Sousa, Bárbara. "P-cadherin aberrant expression is associated with hypoxic/ glycolytic and acid resistant phenotype in breast carcinomas". Trabalho apresentado em 2nd I3S Annual Meeting, Povoa de Varzim, Portugal, 2011.
  35. Sousa, Bárbara. "P-cadherin aberrant expression is associated with hypoxic/ glycolytic and acid resistant phenotype in breast carcinomas". Trabalho apresentado em European Network of breast development and cancer workshop, Weggis, Switzerland, 2011.
  36. Sousa, Bárbara. "P-cadherin aberrant expression is associated with hypoxic/ glycolytic and acid resistant phenotype in breast carcinomas". Trabalho apresentado em 1st Advanced Summer School - Interrogations at the Biointerface, Porto, Portugal, 2011.
  37. Sousa, Bárbara. "P-cadherin, Vimentin and CK14 for identification of basal-like phenotype in breast carcinomas: an immunohistochemical study". Trabalho apresentado em I3S Annual Meeting, Póvoa do Varzim, Portugal, 2010.
  38. Sousa, Bárbara. "P-cadherin, Vimentin and CK14 for identification of basal-like phenotype in breast carcinomas: an immunohistochemical study". Trabalho apresentado em XXXV Jornadas Portuguesas de Genética, Braga, Portugal, 2010.
Tese / Dissertação
  1. "P-cadherin-mediated cell-cell adhesion: Its role on immune evasion in metastasis breast cancer". Mestrado, Universidade de Aveiro, 2023.
  2. "Joana Sousa Pereira: Targeting anoikis-resistant P-cadherin-enriched breast cancer cells by in vitro metabolic reprograming". Mestrado, Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, 2017.
  3. Sousa, Bárbara. "Underlying the role of P-cadherin expression in breast cancer cell metabolism". Doutoramento, 2014.
  4. Sousa, Bárbara. "Immunohistochemical characterization of a series of invasive breast carcinomas using Tissue Microarrays". Licenciatura, 2007.
Atividades

Apresentação oral de trabalho

Título da apresentação Nome do evento
Anfitrião (Local do evento)
2023/05/10 P-cadherin-mediated cell-cell adhesion: its role on immune evasion in metastatic breast cancer (co-supervision) IJUP Edition, Encontro de Investigação Jovem, Porto, Portugal
(Porto, Portugal)
2022/05/04 P-cadherin as a phenotypic stability factor of the Hybrid Epithelial / Mesenchymal phenotype in Breast Cancer (co-supervision) 15th Encontro de Investigação Jovem da Universidade do Porto
(Porto, Portugal)
2021/11/19 P-cadherin as a phenotypic stability factor of the hybrid epithelial/mesenchymal phenotype in breast cancer (co-supervision) 18th National Congress on Oncology, November
Sociedade Portuguesa de Oncologia
2019/11 The anti-oxidant activity of P-cadherin promotes metastasis and therapy resistance in breast cancer 8th i3S Annual Meeting
(Povoa de Varzim, Portugal)
2019/09 P-cadherin induces anoikis resistance in breast cancer stem cells by rewiring the metabolic flux and activating of antioxidant systems Oncometabolism: From Conceptual Knowledge to Clinical Applications
(Luso, Portugal)
2019/09 The anti-oxidant activity of P-cadherin promotes metastasis and doxorubicin resistance in breast cancer MAC’19- 6th Biannual Meeting on Mitochondria, Apoptosis & Cancer
(Praga, República Checa)
2019/01 Circulating CSCs: how to survive upon metabolic alterations caused by matrix detachment CANCEL STEM Consortium Meeting
UC-Biotech, Cantanhede, Portugal (Cantanhede, Portugal)
2018/10 P-cadherin promotes anoikis resistance in breast cancer stem cells by stimulating the glycolytic behavior and lowering the oxidative stress ISCaM 5th annual Meeting- Metabolic Adaptations and targets in Cancer, from International Society of Cancer Metabolism
(Bratislava, Eslováquia)
2017/10 P-cadherin expression: its role in the regulation of metabolic properties of breast cancer stem cells 10th International Meeting of the Portuguese Society for Stem Cells and Cell Therapies (SPCE-TC)
(Covilhã, Portugal)
2017/07 P-cadherin expression: its role in the regulation of metabolic properties of breast cancer stem cells FEBS ADVANCED LECTURE COURSE ON ONCOMETABOLISM: From Conceptual Knowledge to Clinical Applications
(Figueira da Foz, Portugal)
2016/11 P-cadherin: an antioxidant for metabolic defects in breast cancer stem cells 5th I3S Scientific Retreat, IBMC/INEB/IPATIMUP
(Povoa de Varzim, Portugal)
2015/10 P-cadherin expression: its role in the regulation of metabolic properties of breast cancer stem cells 7th International Meeting of the Portuguese Society for Stem Cells and Cell Therapies (SPCE-TC)
(Lisboa, Portugal)
2014/05 E-cadherin and P-cadherin: their crosstalk in breast cancer cells 5th French Cell Adhesion Club Symposium
(Marselha, França)

Orientação

Título / Tema
Papel desempenhado 		Curso (Tipo)
Instituição / Organização
2024/07/01 - Atual In vitro 3D breast cancer spheroids: comparison of different cell lines from distinct molecular subtypes (supervision)
Orientador
 Oncologia (Mestrado)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
2023/01/01 - Atual P-cadherin-mediated cell-cell adhesion: its role in hybrid E/M phenotype and immune evasion in metastatic breast cancer (co-supervision)
Coorientador
 Patologia e Genética Molecular (Doutoramento)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
2020 - Atual The role of cell-cell adhesion in the survival of inflammatory breast cancer tumor emboli (co-supervision)
Coorientador
 Patologia e Genética Molecular (Doutoramento)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
2022/09/01 - 2023/09/30 P-cadherin-mediated cell-cell adhesion: its role on immune evasion in metastatic breast cancer (co-supervision)
Coorientador
 Mestrado em Bioquímica Clínica (Mestrado)
Universidade de Aveiro, Portugal
2019/01/01 - 2019/06/30 Evaluate the role of P-cadherin in the doxorubicin resistance of breast cancer stem cells (co-supervision)
Coorientador
 Bio-Medical Laboratory Technology bachelor (Licenciatura/Bacharelato)
Universiteit Gent, Bélgica
2016/09 - 2017/09 Targeting anoikis-resistant P-cadherin-enriched Breast Cancer Cells by in vitro Metabolic Reprograming
Coorientador
 Bioquímica (Mestrado)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal

Participação em evento

Descrição da atividade
Tipo de evento 		Nome do evento
Instituição / Organização
2024/01/13 - Atual Ciencia et al- i3s Educational Program
Oficina (workshop)
 A Herança dos Maias
Universidade do Porto Instituto de Investigação e Inovação em Saúde, Portugal
2023/10/01 - Atual Science Ambassador at i3S Educational Program: Circulating Tumor Cells and Breast Cancer
Exposição
 Ciencia et al
Universidade do Porto Instituto de Investigação e Inovação em Saúde, Portugal
2023 - Atual Exposição coletiva de Fotografias “O CANCRO VISTO AO MICROSCÓPIO”
Exposição
 Exposição coletiva de Fotografias “O CANCRO VISTO AO MICROSCÓPIO”
Universidade de Aveiro, Portugal
2007 - Atual Participation in "Ciência Viva" exhibitions
Ciência Viva, Portugal
2007 - Atual Dissemination of scientific research within an exhibition promoted by University of Porto targeting high school students: MOSTRA UP MOSTRA UP
Universidade do Porto, Portugal
2014/11/14 - 2014/11/15 Ipatimup - 2 Dias Abertos
Exposição
Universidade do Porto Instituto de Patologia e Imunologia Molecular, Portugal
2014/05/05 - 2014/05/12 Exposição: Cancro, Ciência e Cidade: Os Passos da Ciência nos Paços do Concelho
Encontro
 Exposição: Cancro, Ciência e Cidade: Os Passos da Ciência nos Paços do Concelho
Universidade do Porto Instituto de Patologia e Imunologia Molecular, Portugal

Câmara Municipal do Porto, Portugal

Júri de grau académico

Tema
Tipo de participação 		Nome do candidato (Tipo de grau)
Instituição / Organização
2023/11/30 Tumor spheroids as 3D models to evaluate the efficacy of Azurin-expressing Mesenchymal Stromal Cells-secretome as a potential anticancer therapy
Arguente principal
 Alexandra Amaral Barbosa (Mestrado)
Universidade de Lisboa Instituto Superior Técnico, Portugal

Comissão de avaliação

Descrição da atividade
Tipo de assessoria 		Instituição / Organização Entidade financiadora
2018/02 - 2018/02 Avaliador/Moderador de sessão de comunicações orais no 11º Encontro de Jovens Investigadores da U.PORTO
Avaliador

Curso / Disciplina lecionado

Disciplina Curso (Tipo) Instituição / Organização
2019 - 2020 Participation in Invasion and Mestatasis module Medicina (Mestrado integrado) Universidade do Porto Faculdade de Medicina, Portugal
2018 - 2019 Participation in Invasion and Mestatasis module Medicina (Mestrado integrado) Universidade do Porto Faculdade de Medicina, Portugal
2018 - 2019 Participation in Oncometabolism module at BEB PhD programme Biologia Experimental e Biomedicina (Doutoramento) Universidade de Coimbra, Portugal
2017 - 2018 Participation in Oncobiology module in the lesson: Cancer stemness and differentiation 20th GABBA Edition (Curso de doutoramento (conclusão de unidades curriculares)) Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
2017 - 2018 Participation in Invasion and Mestatasis module Medicina (Mestrado integrado) Universidade do Porto Faculdade de Medicina, Portugal
Distinções

Prémio

2023 Fulbright award: "Studying the impact of cell-cell adhesion on the metastatic process of Inflammatory Breast Cancer" (co-supervision)
Fulbright Portugal, Portugal
2022 Bolsa de Investigação em Oncologia LPCC-NRS 2022 (co-supervision)
Liga Portuguesa Contra o Cancro, Portugal
2022 Best Oral Communication at 15th Encontro de Investigação Jovem da Universidade do Porto 2022 (co-supervision)
2021 Best Oral Communication at 18th National Congress on Oncology 2021 (co-supervision)
2012 3rd Award of Oncology poster session in 3rd I3S Scientific Retreat – IBMC/INEB/IPATIMUP, Póvoa de Varzim, Portugal.
2012 Best Poster Award - mTOR expression in basal-like breast cancer and the ability of Everolimus to inhibit the invasion cancer cell capacity (co-author)